Red blood cell (RBC) transfusion is an essential practice in modern medicine, one that is entirely dependent on the availability of donor blood. Constraints in donor supply have led to proposals that transfusible RBC could be manufactured from stem cells. While it is possible to generate small amounts of RBC in vitro, very large numbers of cells are required to be of clinical significance. We explore the challenges facing large scale manufacture of RBC and technological developments required for such a scenario to be realised
In vitro generation of artificial red blood cells (RBCs) is very important to overcome insufficient ...
Although the current system of blood transfusion is relatively safe and established within the UK, p...
Transfusion of donor-derived red blood cells (RBC) is the most common form of cellular therapy. Dono...
Recent advances have increased excitement about the potential for therapeutic production of red bloo...
A shortage of blood during the pandemic outbreak of COVID-19 is a typical example in which the maint...
Blood transfusion depends on availability of donor material, and concerns over supply and safety hav...
Recent advances have increased excitement about the potential for therapeutic production of red bloo...
Provision of a safe and secure supply of transfusible red blood cells (RBC) is a major global health...
Blood transfusions have become indispensable to treat the anemia associated with a variety of medica...
To date, the use of red blood cells (RBCs) produced from stem cells in vitro has not proved practica...
Unpredictable adverse results can ensue from blood transfusion therapies because of the donation of ...
Blood transfusion and especially red blood cell (RBC) transfusion is an essential therapeutic act be...
Whilst red cell transfusion is a well established cellular therapy, the problems of insufficiency of...
International audienceIn vitro RBC production from stem cells could represent an alternative to clas...
The short shelf life along with the constant threat or an actual shortage of red blood cells (RBCs) ...
In vitro generation of artificial red blood cells (RBCs) is very important to overcome insufficient ...
Although the current system of blood transfusion is relatively safe and established within the UK, p...
Transfusion of donor-derived red blood cells (RBC) is the most common form of cellular therapy. Dono...
Recent advances have increased excitement about the potential for therapeutic production of red bloo...
A shortage of blood during the pandemic outbreak of COVID-19 is a typical example in which the maint...
Blood transfusion depends on availability of donor material, and concerns over supply and safety hav...
Recent advances have increased excitement about the potential for therapeutic production of red bloo...
Provision of a safe and secure supply of transfusible red blood cells (RBC) is a major global health...
Blood transfusions have become indispensable to treat the anemia associated with a variety of medica...
To date, the use of red blood cells (RBCs) produced from stem cells in vitro has not proved practica...
Unpredictable adverse results can ensue from blood transfusion therapies because of the donation of ...
Blood transfusion and especially red blood cell (RBC) transfusion is an essential therapeutic act be...
Whilst red cell transfusion is a well established cellular therapy, the problems of insufficiency of...
International audienceIn vitro RBC production from stem cells could represent an alternative to clas...
The short shelf life along with the constant threat or an actual shortage of red blood cells (RBCs) ...
In vitro generation of artificial red blood cells (RBCs) is very important to overcome insufficient ...
Although the current system of blood transfusion is relatively safe and established within the UK, p...
Transfusion of donor-derived red blood cells (RBC) is the most common form of cellular therapy. Dono...